Clin2Atlas
AtlasInjuriesSelf-harm and interpersonal violence

Conflict and terrorism

1SymptomaticAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251992 — Octinoxate approved (FDA)1992 — Thiosulfuric acid approved (FDA)1992 — Avobenzone approved (FDA)1995 — Dexrazoxane approved (FDA)1995 — Alendronic acid approved (FDA)1996 — Ibandronic acid approved (FDA)1996 — Cefepime approved (FDA)1998 — Perflenapent approved (FDA)2000 — Isopropyl alcohol approved (FDA)2001 — Sulfur hexafluoride approved (FDA)2001 — Eptotermin alfa approved (FDA)2001 — Zoledronic acid anhydrous approved (FDA)2002 — Dibotermin alfa approved (FDA)2004 — Pregabalin approved (FDA)2006 — Titanium dioxide approved (FDA)2006 — Zinc oxide approved (FDA)2008 — Methyl salicylate approved (FDA)2008 — Menthol approved (FDA)2009 — Autologous cultured chondrocytes approved (FDA)2009 — Capsaicin approved (FDA)2016 — Birch triterpenes approved (FDA)2020 — Flortaucipir approved (FDA)2023 — Beremagene geperpavec approved (FDA)
1992: Drug approval — Octinoxate approved (FDA). 1992: Drug approval — Thiosulfuric acid approved (FDA). 1992: Drug approval — Avobenzone approved (FDA). 1995: Drug approval — Dexrazoxane approved (FDA). 1995: Drug approval — Alendronic acid approved (FDA). 1996: Drug approval — Ibandronic acid approved (FDA). 1996: Drug approval — Cefepime approved (FDA). 1998: Drug approval — Perflenapent approved (FDA). 2000: Drug approval — Isopropyl alcohol approved (FDA). 2001: Drug approval — Sulfur hexafluoride approved (FDA). 2001: Drug approval — Eptotermin alfa approved (FDA). 2001: Drug approval — Zoledronic acid anhydrous approved (FDA). 2002: Drug approval — Dibotermin alfa approved (FDA). 2004: Drug approval — Pregabalin approved (FDA). 2006: Drug approval — Titanium dioxide approved (FDA). 2006: Drug approval — Zinc oxide approved (FDA). 2008: Drug approval — Methyl salicylate approved (FDA). 2008: Drug approval — Menthol approved (FDA). 2009: Drug approval — Autologous cultured chondrocytes approved (FDA). 2009: Drug approval — Capsaicin approved (FDA). 2016: Drug approval — Birch triterpenes approved (FDA). 2020: Drug approval — Flortaucipir approved (FDA). 2023: Drug approval — Beremagene geperpavec approved (FDA)

What's being tested now

2000: 1 trials started2001: 1 trials started2002: 2 trials started2003: 1 trials started2004: 4 trials started2005: 2 trials started2006: 1 trials started2007: 3 trials started2008: 2 trials started2009: 2 trials started2010: 6 trials started2011: 8 trials started2012: 10 trials started2013: 16 trials started2014: 20 trials started2015: 13 trials started2016: 25 trials started2017: 49 trials started2018: 54 trials started2019: 89 trials started2020: 88 trials started2021: 205 trials started2022: 235 trials started2023: 393 trials started2024: 720 trials started2025: 975 trials started2026: 948 trials started2000201020202026975

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 3599 active Abdominal Injury trials on Clin2 →

Related

Police conflict and executions

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.